Back to Top
Go Back
Journal Photo for Expert Review of Anticancer Therapy
Peer reviewed only Open Access

Expert Review of Anticancer Therapy (ERAThttps://www.tandfonline.com/journals/iery20)

Publisher : Taylor & Francis
Biomarkers Diagnostics Clinical trials
Claim Your Journal Get PRC Visit Website
e-ISSN 1744-8328
p-ISSN 1473-7140
Issue Frequency Monthly
Impact Factor 2.9
Est. Year 2001
Mobile 4402080520500
DOI YES
Language English
APC YES
Impact Factor Assignee GOOGLE SCHOLAR
Email enquiries@taylorandfrancis.com

Journal Descriptions

Expert Review of Anticancer Therapy [ISSN 1473-7140]; [e-ISSN 1744-8328] is a MEDLINE-indexed, international subscription-based journal publishing comprehensive peer-reviewed content on the major issues in clinical oncology. Coverage in the journal is focused on, but not limited to, the following key areas: Anticancer agents Novel therapies in development Cancer management Biomarkers Diagnostics Clinical trials Treatment guidelines The journal welcomes clinically focused original research, reviews, editorials and drug profile articles. Please note that the journal does not accept case reports or case series and does not accept papers focused on pre-clinical work and/or animal studies. Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Expert Review of Anticancer Therapy (ERAThttps://www.tandfonline.com/journals/iery20) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Biomarkers, Diagnostics, Clinical trials, Treatment guidelines, Anticancer agents, Novel therapies in development , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1473-7140, E-ISSN: 1744-8328, Established: 2001, Impact Factor: 2.9
  • Provides Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing